3-9943452-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBS1BS2
The NM_001077415.3(CRELD1):c.985C>T(p.Arg329Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000781 in 1,613,968 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00081 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 2 hom. )
Consequence
CRELD1
NM_001077415.3 missense
NM_001077415.3 missense
Scores
6
5
8
Clinical Significance
Conservation
PhyloP100: 3.61
Publications
16 publications found
Genes affected
CRELD1 (HGNC:14630): (cysteine rich with EGF like domains 1) This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.30895013).
BP6
Variant 3-9943452-C-T is Benign according to our data. Variant chr3-9943452-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 3427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000808 (123/152156) while in subpopulation NFE AF = 0.00132 (90/67992). AF 95% confidence interval is 0.0011. There are 0 homozygotes in GnomAd4. There are 58 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRELD1 | NM_001077415.3 | c.985C>T | p.Arg329Cys | missense_variant | Exon 10 of 11 | ENST00000452070.6 | NP_001070883.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CRELD1 | ENST00000452070.6 | c.985C>T | p.Arg329Cys | missense_variant | Exon 10 of 11 | 2 | NM_001077415.3 | ENSP00000393643.2 | ||
| ENSG00000288550 | ENST00000683484.1 | n.*633C>T | non_coding_transcript_exon_variant | Exon 23 of 24 | ENSP00000507040.1 | |||||
| ENSG00000288550 | ENST00000683484.1 | n.*633C>T | 3_prime_UTR_variant | Exon 23 of 24 | ENSP00000507040.1 |
Frequencies
GnomAD3 genomes AF: 0.000809 AC: 123AN: 152038Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
123
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000648 AC: 163AN: 251408 AF XY: 0.000662 show subpopulations
GnomAD2 exomes
AF:
AC:
163
AN:
251408
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000778 AC: 1137AN: 1461812Hom.: 2 Cov.: 33 AF XY: 0.000760 AC XY: 553AN XY: 727216 show subpopulations
GnomAD4 exome
AF:
AC:
1137
AN:
1461812
Hom.:
Cov.:
33
AF XY:
AC XY:
553
AN XY:
727216
show subpopulations
African (AFR)
AF:
AC:
10
AN:
33478
American (AMR)
AF:
AC:
23
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26134
East Asian (EAS)
AF:
AC:
1
AN:
39700
South Asian (SAS)
AF:
AC:
9
AN:
86258
European-Finnish (FIN)
AF:
AC:
16
AN:
53412
Middle Eastern (MID)
AF:
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1030
AN:
1111950
Other (OTH)
AF:
AC:
42
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
68
136
203
271
339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000808 AC: 123AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000780 AC XY: 58AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
123
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
58
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
13
AN:
41508
American (AMR)
AF:
AC:
17
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5152
South Asian (SAS)
AF:
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
AC:
1
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
90
AN:
67992
Other (OTH)
AF:
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
14
ExAC
AF:
AC:
77
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
CRELD1: BS2 -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Atrioventricular septal defect, susceptibility to, 2 Benign:1Other:1
Mar 31, 2014
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;.;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;M;M
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N
REVEL
Pathogenic
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
D;D;D;D
Vest4
MVP
MPC
0.23
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.